Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 120

Similar articles for PubMed (Select 9292341)

1.

Testosterone treatment of clinical hypogonadism in patients with HIV/AIDS.

Rabkin JG, Rabkin R, Wagner GJ.

Int J STD AIDS. 1997 Sep;8(9):537-45. Review.

PMID:
9292341
2.

Testosterone therapy for clinical symptoms of hypogonadism in eugonadal men with AIDS.

Wagner GJ, Rabkin JG.

Int J STD AIDS. 1998 Jan;9(1):41-4.

PMID:
9518014
3.

A double-blind, placebo-controlled trial of testosterone therapy for HIV-positive men with hypogonadal symptoms.

Rabkin JG, Wagner GJ, Rabkin R.

Arch Gen Psychiatry. 2000 Feb;57(2):141-7; discussion 155-6.

PMID:
10665616
4.

Testosterone therapy for human immunodeficiency virus-positive men with and without hypogonadism.

Rabkin JG, Wagner GJ, Rabkin R.

J Clin Psychopharmacol. 1999 Feb;19(1):19-27.

PMID:
9934939
5.

Testosterone replacement treatment options for HIV-infected men.

Cofrancesco J Jr, Whalen JJ 3rd, Dobs AS.

J Acquir Immune Defic Syndr Hum Retrovirol. 1997 Dec 1;16(4):254-65. Review.

PMID:
9402072
6.

Testosterone replacement for hypogonadism: clinical findings and best practices.

Hengge UR.

AIDS Read. 2003 Dec;13(12 Suppl):S15-21. Review.

PMID:
14959695
7.

Prevalence of hypogonadism among men with weight loss related to human immunodeficiency virus infection who were receiving highly active antiretroviral therapy.

Rietschel P, Corcoran C, Stanley T, Basgoz N, Klibanski A, Grinspoon S.

Clin Infect Dis. 2000 Nov;31(5):1240-4. Epub 2000 Nov 2.

8.

Androgen therapy in AIDS wasting.

Dobs AS.

Baillieres Clin Endocrinol Metab. 1998 Oct;12(3):379-90. Review.

PMID:
10332560
9.

The management of hypogonadism in aging male patients.

Sharma V, Perros P.

Postgrad Med. 2009 Jan;121(1):113-21. doi: 10.3810/pgm.2009.01.1960.

PMID:
19179819
11.

Testosterone replacement therapy for the primary care physician.

Casey RW, Barkin J.

Can J Urol. 2008 Aug;15 Suppl 1:71-7; discussion 77. Review.

PMID:
18700068
12.

Testosterone metabolism and replacement therapy in patients with end-stage renal disease.

Johansen KL.

Semin Dial. 2004 May-Jun;17(3):202-8. Review.

PMID:
15144546
13.

Testosterone as a treatment for fatigue in HIV+ men.

Wagner GJ, Rabkin JG, Rabkin R.

Gen Hosp Psychiatry. 1998 Jul;20(4):209-13.

PMID:
9719899
15.

Effects of androgen administration in men with the AIDS wasting syndrome. A randomized, double-blind, placebo-controlled trial.

Grinspoon S, Corcoran C, Askari H, Schoenfeld D, Wolf L, Burrows B, Walsh M, Hayden D, Parlman K, Anderson E, Basgoz N, Klibanski A.

Ann Intern Med. 1998 Jul 1;129(1):18-26.

PMID:
9652995
16.

Erectile dysfunction in men with HIV-1: effect of hypogonadism and antiretroviral therapy.

Chan DJ.

J HIV Ther. 2007 Jun;12(2):54-8. Review. No abstract available.

PMID:
17641574
17.

Testosterone replacement therapy: current trends and future directions.

Nieschlag E, Behre HM, Bouchard P, Corrales JJ, Jones TH, Stalla GK, Webb SM, Wu FC.

Hum Reprod Update. 2004 Sep-Oct;10(5):409-19. Epub 2004 Aug 5. Review.

18.

Sustained anabolic effects of long-term androgen administration in men with AIDS wasting.

Grinspoon S, Corcoran C, Anderson E, Hubbard J, Stanley T, Basgoz N, Klibanski A.

Clin Infect Dis. 1999 Mar;28(3):634-6.

19.

Hypogonadism in the man with erectile dysfunction: what to look for and when to treat.

Lazarou S, Morgentaler A.

Curr Urol Rep. 2005 Nov;6(6):476-81. Review.

PMID:
16238923
20.

The use of testosterone in the AIDS wasting syndrome.

Corcoran C, Grinspoon S.

AIDS Clin Care. 1999 Apr;11(4):25-6, 33-4.

PMID:
11366208
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk